Quantcast

Latest Pandemics Stories

2014-06-25 08:29:39

BEIJING, June 25, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the value added tax (or "VAT") rate applied to the sales of Sinovac's vaccine products will be reduced to 3% from the current rate of 6%, according to a joint notice on reducing and unifying the value added tax (VAT) rate published by the Ministry of Finance of China and State Administration of Taxation of China. The notification...

egyptian plague burial site
2014-06-18 05:03:21

redOrbit Staff & Wire Reports - Your Universe Online A team of Italian archaeologists has uncovered the remains of ancient plague victims at an ancient burial plot in what is now Luxor, Egypt, according to research appearing in the latest edition of the Egypt Exploration Society journal Egyptian Archaeology. Between 250 AD and 271 AD, as many as 5,000 people died each day as a result of the disease, explained Owen Jarus in an article published by LiveScience. The epidemic became...

2014-06-16 16:25:10

AMES, Iowa, June 16, 2014 /PRNewswire/ -- Ames, Iowa-based vaccine producer, Harrisvaccines, today announced it has been granted United States Department of Agriculture (USDA) conditional licensure of the company's Porcine Epidemic Diarrhea Virus (PEDv) Vaccine, RNA utilizing its SirraVax(SM )RNA Particle Technology. This is the first USDA conditional license granted for a PEDv vaccine since the initial outbreak, and it will allow Harrisvaccines to sell their vaccine directly to the...

2014-06-09 23:06:34

Markets Research Reports.biz added deep and professional market research report on "Global Influenza [Flu] Vaccine Market Trends and Opportunities 2014-19" Market Analysis and Overview. Albany, NY (PRWEB) June 09, 2014 With the advancement in technology and discovery of new products in the field of medical sciences, vaccines have gained a crucial position in the pharmaceutical industry. Vaccines are considered as the most effective health intervention ever developed, saving...

Cholera In Sudan, Ebola Threat In Sierra Leone, MERS Invades Algeria
2014-06-03 08:22:51

Lawrence LeBlond for redOrbit.com - Your Universe Online CHOLERA The Ministry of Health of South Sudan declared a cholera outbreak in Juba on May 15, 2014 after four cases were laboratory confirmed following tests conducted by the African Medical Research Foundation in Nairobi, Kenya. The first case identified with onset of illness was on April 23. As of May 25, a total of 586 cholera cases had been reported, including 22 deaths – 13 hospital and 9 community deaths. The majority of...

2014-05-21 10:33:18

Harvard School of Public Health Research in mammals that aims to prevent future influenza pandemics raises ethical, public health concerns Experiments creating dangerous flu strains that are transmissible between mammals pose too great a risk to human life from potential release, according to an editorial by researchers from Harvard School of Public Health (HSPH) and Yale School of Public Health. The researchers are calling for greater scrutiny of experiments that make virulent...

2014-05-20 12:33:52

OTTAWA, May 20, 2014 /CNW/ - The United States, Canada and Mexico have adopted a set of principles and guidelines on how the three countries' governments will share in advance public information and communications products during health emergencies of mutual interest. U.S. Health and Human Services Secretary Kathleen Sebelius, Canada's Minister of Health Rona Ambrose and Mexico's Secretary of Health Mercedes Juan signed a Declaration of Intent, formally adopting the principles and...

2014-05-19 08:28:40

Global Target Established: Replikins Identical in Humans and Camels; Anti-Mers-CoV Replikins Vaccine(TM) Available and Testing Has Started LONDON, May 19, 2014 /PRNewswire-USNewswire/ -- In an analysis of the human specimen gene sequences published Saturday, May 17 by PubMed, Bioradar UK, Ltd. found the Replikin gene sequences of the human Mers-CoV specimens in Florida and Indiana to contain identical Replikin gene sequences to those from other countries. These new findings followed BioRadar...

2014-05-16 12:27:03

Anti-Mers-CoV Synthetic Replikins Vaccine(TM) Available Now to Vaccinate Camels LONDON, May 16, 2014 /PRNewswire/ -- A Replikins analysis by Bioradar, Ltd of Mers-CoV in all isolates of the virus genes reported to date in Pubmed from both humans and camels has revealed specific shared gene Replikin structures that are not just homologous but are identical in the virus genes infecting both camels and humans, and conserved since 2012 in cases from all countries affected. Replikins, Ltd. has...

2014-05-15 12:36:33

LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global H1N1 Vaccines Industryhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/global_h1n1_vaccines_industry.html This report analyzes the Global market for H1N1 Vaccines in US$ Million. The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2018. The...


Latest Pandemics Reference Libraries

72_f634c1b2916580c60814457a175ea810
2011-04-28 15:06:23

Vibrio cholerae is a gram negative comma-shaped bacterium with a polar flagellum that causes cholera in humans. V. cholerae belongs to the gamma subdivision of the Proteobacteria. Classical and El Tor are the two types of V. Cholerae identified by hemaggluttination testing. El Tor is found throughout the world, while the classical biotype is found only in Bangladesh. It was first isolated as the cause of cholera by Italian anatomist Filippo Pacini in 1854; however, this discovery was not...

More Articles (1 articles) »
Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related